Literature DB >> 7560020

Epidemiology of status epilepticus.

R J DeLorenzo1, J M Pellock, A R Towne, J G Boggs.   

Abstract

This study presents a review of the epidemiology of status epilepticus (SE) in Richmond, Virginia, U.S.A. The data summarize some of the first population-based information on the natural presentation of SE in a controlled community setting. SE occurred with an absolute incidence rate of 41 patients per 100,000 residents per year in Richmond. The frequency of total SE occurrences was 50 patients per 100,000 residents per year. Overall mortality in this population was 22%. Absolute incidence and occurrences of SE in this population were shown to be underestimates due to the inability, for multiple reasons, to document all cases of SE. Based on the Richmond data, the number of SE cases, frequencies of occurrence, and deaths per year occurring in the United States were estimated to be 102,000-152,000, 125,000-195,000, and 22,000-42,000, respectively. In Richmond, nonwhites had a much higher incidence of SE than did whites. Partial SE was the most common form of seizure initiating SE. Age and etiology were also found to contribute to mortality. Infants <1 year of age had the highest incidence of SE, but the elderly population represented the largest number of SE cases. This study provides a review of the first prospective, population-based, epidemiological data on SE and shows that SE is a major medical and neurological emergency in both academic and community hospital settings.

Entities:  

Mesh:

Year:  1995        PMID: 7560020

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  80 in total

1.  Epilepsy: MRI follow-up in paediatric convulsive status epilepticus.

Authors:  Rima Nabbout; Olivier Dulac
Journal:  Nat Rev Neurol       Date:  2012-04-17       Impact factor: 42.937

Review 2.  Benzodiazepine-refractory status epilepticus: pathophysiology and principles of treatment.

Authors:  Jerome Niquet; Roger Baldwin; Lucie Suchomelova; Lucille Lumley; David Naylor; Roland Eavey; Claude G Wasterlain
Journal:  Ann N Y Acad Sci       Date:  2016-07-08       Impact factor: 5.691

3.  Recent and future advances in the treatment of status epilepticus.

Authors:  Felix Rosenow; Susanne Knake
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

Review 4.  Outcome of convulsive status epilepticus: a review.

Authors:  Claire L Novorol; Richard F M Chin; Rod C Scott
Journal:  Arch Dis Child       Date:  2007-11       Impact factor: 3.791

Review 5.  Development of the calcium plateau following status epilepticus: role of calcium in epileptogenesis.

Authors:  Nisha Nagarkatti; Laxmikant S Deshpande; Robert J DeLorenzo
Journal:  Expert Rev Neurother       Date:  2009-06       Impact factor: 4.618

6.  Endocannabinoids block status epilepticus in cultured hippocampal neurons.

Authors:  Laxmikant S Deshpande; Robert E Blair; Julie M Ziobro; Sompong Sombati; Billy R Martin; Robert J DeLorenzo
Journal:  Eur J Pharmacol       Date:  2006-11-22       Impact factor: 4.432

Review 7.  Status epilepticus: pathophysiology, epidemiology, and outcomes.

Authors:  R C Scott; R A Surtees; B G Neville
Journal:  Arch Dis Child       Date:  1998-07       Impact factor: 3.791

8.  Status epilepticus.

Authors:  Ajith Cherian; Sanjeev V Thomas
Journal:  Ann Indian Acad Neurol       Date:  2009-07       Impact factor: 1.383

9.  Development of pharmacoresistance to benzodiazepines but not cannabinoids in the hippocampal neuronal culture model of status epilepticus.

Authors:  Laxmikant S Deshpande; Robert E Blair; Nisha Nagarkatti; Sompong Sombati; Billy R Martin; Robert J DeLorenzo
Journal:  Exp Neurol       Date:  2007-01-09       Impact factor: 5.330

10.  Prognostic factors of status epilepticus in children.

Authors:  Du Cheol Kang; Young-Mock Lee; JoonSoo Lee; Heung Dong Kim; ChangJun Coe
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.